We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$27.7B
AUM Growth
+$2.29B
Cap. Flow
+$341M
Cap. Flow %
1.23%
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$113M
2
AAPL icon
Apple
AAPL
+$69M
3
PFE icon
Pfizer
PFE
+$57M
4
VZ icon
Verizon
VZ
+$50.4M
5
MSFT icon
Microsoft
MSFT
+$48.6M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$100M
2
LIN icon
Linde
LIN
+$85.1M
3
ABMD
Abiomed Inc
ABMD
+$55.4M
4
RACE icon
Ferrari
RACE
+$51.7M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 27.03%
2 Healthcare 20.96%
3 Financials 10.74%
4 Consumer Discretionary 10.18%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANET icon
251
Arista Networks
ANET
$199B
$26.5M 0.1%
873,196
+862,740
+8,251% +$26.6M
O icon
252
Realty Income
O
$61.1B
$26.4M 0.1%
416,850
+6,163
+2% +$383K
SJM icon
253
J.M. Smucker
SJM
$13.5B
$26.4M 0.1%
166,466
+17,081
+11% +$2.54M
WM icon
254
Waste Management
WM
$95B
$26.3M 0.1%
167,953
-24,500
-13% -$3.94M
SUI icon
255
Sun Communities
SUI
$15.8B
$26.2M 0.09%
182,985
+42,421
+30% +$5.79M
TKR icon
256
Timken Company
TKR
$9.19B
$26.1M 0.09%
368,700
+274,700
+292% +$19.2M
TNDM icon
257
Tandem Diabetes Care
TNDM
$1.27B
$26M 0.09%
579,259
+92,349
+19% +$4.18M
IBM icon
258
IBM
IBM
$213B
$26M 0.09%
184,391
-44,215
-19% -$6.1M
ZBRA icon
259
Zebra Technologies
ZBRA
$13.5B
$25.9M 0.09%
+101,005
New +$26.1M
PDD icon
260
Pinduoduo
PDD
$126B
$25.8M 0.09%
316,552
+36,479
+13% +$2.54M
MRSH
261
Marsh
MRSH
$94.3B
$25.8M 0.09%
155,702
-8,524
-5% -$1.39M
LVS icon
262
Las Vegas Sands
LVS
$32.2B
$25.5M 0.09%
530,816
-105,920
-17% -$4.49M
JCI icon
263
Johnson Controls International
JCI
$85.1B
$25.4M 0.09%
396,284
-10,828
-3% -$662K
CB icon
264
Chubb
CB
$140B
$25.1M 0.09%
113,986
-152,809
-57% -$31.8M
STLD icon
265
Steel Dynamics
STLD
$36.4B
$25.1M 0.09%
257,326
+17,180
+7% +$1.65M
SWK icon
266
Stanley Black & Decker
SWK
$14.5B
$25.1M 0.09%
+333,552
New +$26M
WPM icon
267
Wheaton Precious Metals
WPM
$49.7B
$24.9M 0.09%
637,549
+116,972
+22% +$4.23M
MDT icon
268
Medtronic
MDT
$112B
$24.9M 0.09%
320,405
+9,055
+3% +$734K
ARGX icon
269
argenx
ARGX
$55.2B
$24.3M 0.09%
64,184
-214
-0.3% -$80K
CCI icon
270
Crown Castle
CCI
$34.6B
$24.1M 0.09%
177,674
-3,696
-2% -$500K
MNST icon
271
Monster Beverage
MNST
$95.1B
$23.7M 0.09%
466,878
-59,286
-11% -$2.87M
NEWR
272
DELISTED
New Relic, Inc.
NEWR
$23.5M 0.08%
415,733
+5,598
+1% +$317K
AZPN
273
DELISTED
Aspen Technology Inc
AZPN
$23.1M 0.08%
112,283
-20,943
-16% -$4.87M
MSI icon
274
Motorola Solutions
MSI
$72.1B
$22.9M 0.08%
88,972
+520
+0.6% +$130K
JLL icon
275
Jones Lang LaSalle
JLL
$15.8B
$22.9M 0.08%
143,798
+4,846
+3% +$773K

Similar funds

Axa's Q4 2022 Portfolio in Review

As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
  • Axa added most to Tesla in Q4 2022, an estimated $113M increase.
  • Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
  • Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
  • Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
  • Axa opened 118 new positions and closed 119 in Q4 2022.
  • Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.